0001213900-23-086163.txt : 20231113
0001213900-23-086163.hdr.sgml : 20231113
20231113163020
ACCESSION NUMBER: 0001213900-23-086163
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231108
FILED AS OF DATE: 20231113
DATE AS OF CHANGE: 20231113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Runge Jeffrey W.
CENTRAL INDEX KEY: 0001479091
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39336
FILM NUMBER: 231399298
MAIL ADDRESS:
STREET 1: C/O PHARMATHENE, INC., ONE PARK PLACE
STREET 2: SUITE 450
CITY: ANNAPOLIS
STATE: MD
ZIP: 21401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aditxt, Inc.
CENTRAL INDEX KEY: 0001726711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823204328
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 737 N. FIFTH STREET, SUITE 200
CITY: RICHMOND
STATE: VA
ZIP: 23219
BUSINESS PHONE: 909-488-0844
MAIL ADDRESS:
STREET 1: 737 N. FIFTH STREET, SUITE 200
CITY: RICHMOND
STATE: VA
ZIP: 23219
FORMER COMPANY:
FORMER CONFORMED NAME: Aditx Therapeutics, Inc.
DATE OF NAME CHANGE: 20201113
FORMER COMPANY:
FORMER CONFORMED NAME: ADiTx Therapeutics, Inc.
DATE OF NAME CHANGE: 20171229
4
1
ownership.xml
X0508
4
2023-11-08
0
0001726711
Aditxt, Inc.
ADTX
0001479091
Runge Jeffrey W.
C/O ADITXT, INC.
737 N. FIFTH STREET, SUITE 200
RICHMOND
VA
23219
1
0
0
0
0
Options (right to buy)
5.01
2023-11-08
4
A
0
470
0
A
2033-11-08
Common Stock
470
470
D
On November 8, 2023, the Reporting Person was granted options ("Options") to purchase up to 470 shares of the Registrant's common stock pursuant to the Registrant's 2021 Omnibus Equity Incentive Plan. The Options vest fully on the date of grant.
/s/ Jeffrey Runge
2023-11-13